NeoGenomics, Inc. (NEO)
11.80
+0.09
(+0.77%)
USD |
NASDAQ |
Dec 09, 16:00
11.80
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Shareholders Equity (Quarterly): 838.29M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EXACT Sciences Corp. | 2.501B |
| IQVIA Holdings, Inc. | 6.16B |
| Incyte Corp. | 4.651B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Arcturus Therapeutics Holdings, Inc. | 224.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.375B |
| Total Liabilities (Quarterly) | 536.49M |
| Debt to Equity Ratio | 0.4895 |
| Current Ratio | 3.906 |
| Net Debt Paydown Yield | 3.94% |